What is Cytonics?

Cytonics Corporation, headquartered in Jupiter, FL, is a biopharmaceutical research and development Company dedicated towards engineering diagnostics and treatments for osteoarthritis. To-date, the company has developed an impressive portfolio comprising a biomarker assay and two medical devices for treating cartilage damage due to arthritic decay. The company is currently engineering a recombinant protein version of its core technology, which will be the first “off-the-shelf” treatment for osteoarthritis.



Johnson & Johnson

J&J has invested over $4M for 14% of the company


current shareholders

Cytonics has over 100 current shareholders of common and preferred stock


Raised last round

Cytonics raised $794,000 in the last round of financing this year

Press Releases